Key Dates and Safety Measures for the 2021 ASH Annual Meeting
The 63rd American Society of Hematology (ASH) Annual Meeting and Exposition will take place December 11-14, 2021, both in-person at the Georgia World Congress Center in Atlanta and as a virtual meeting for those who prefer to participate online. The meeting will provide attendees an invaluable educational experience, the opportunity to review scientific abstracts highlighting the latest breakthroughs in hematology, and chances to interact with top minds in the field.
The safety of meeting attendees is ASH’s top priority, and the most effective way to ensure the safety of all attendees is for them to be vaccinated against COVID-19. Please note that proof of vaccination will be required for all in-person meeting attendees prior to traveling to Atlanta. In addition, ASH is requiring that all attendees, ASH staff, and convention center workers wear protective masks in the convention center, hotels, shuttle buses, or anywhere an in-person ASH event is being held.
Public health guidance on preventing the transmission of COVID-19 continues to evolve, and ASH will base its on-site protocols on the latest guidance from the CDC in addition to local regulations in Atlanta. Registered attendees will be given specific instructions prior to arriving on site.
Rapid COVID-19 testing stations will be available for those who experience symptoms on site and for travelers who must show proof of a recent negative COVID-19 test in order to board their return flight.
Stay abreast of the latest updates on health and safety protocols for the 63rd ASH Annual Meeting and Exposition at hematology.org/meetings/annual-meeting.
Introducing Hematopoiesis: A Newsletter by Trainees, for Trainees
The ASH Trainee Council is proud to announce the launch of Hematopoiesis, a newsletter for all budding hematologists across the training pipeline.
A reimagining of the former TraineE-News newsletter, Hematopoiesis is part of the Council’s broader mission to provide all levels of trainees with equitable access to educational and career development resources.
In the spirit of mutual learning, Hematopoiesis has introduced several new types of articles, with all content generated by trainees and edited by Trainee Council members. These include:
Delivers high-yield didactics about both fundamental and emerging topics in hematology, such as the evolving use of measurable residual disease, the current landscape of chimeric antigen receptor (CAR) T-cell therapy, and the basics of peripheral blood smear interpretation for hematologists in training.
Presents articles on novel career paths in hematology, such as infusing patient and political advocacy into hematology practice, and practical advice from graduate students on how to begin a research career in the COVID era.
Continues curating educational case studies for trainees, with an emphasis on increasing the variety of cases, including pediatric cases and descriptions of novel hematologic disorders.
The Trainee Council chose the newsletter’s name, which means the formation, maturation, and differentiation of all blood cells, to represent the entire spectrum of hematology trainees, from medical students, housestaff, and fellows to clinicians and graduate researchers, as well as adult and pediatric hematologists. Just like the bone marrow milieu where blood cells are formed, the trainee community is made stronger by its diversity and by uplifting each trainee to succeed in any field of hematology.
The inaugural issue of Hematopoiesis includes a primer on advocacy for the hematology trainee, a Morning Report explaining what fellows need to know about CAR T-cell therapy, and an article about the “Blood Sisters” mentorship buddy program for women hematology/oncology fellows, which aims to increase resilience, reduce burnout, and improve participants’ professional quality of life. Also featured are two case studies, one of a 73-year-old man with extensive bruising and another of a 2.5-year-old girl with fever and pancytopenia.
In an effort to bring even more thought-provoking educational and career-focused hematology content to the community of hematology trainees around the globe, the ASH Trainee Council has simultaneously launched the new Hematopoiesis podcast, which is produced and curated by councilmembers.
In the first episode of the podcast, former ASH Trainee Council Chair Lachelle Dawn Weeks, MD, PhD, begins her three-part series on the mythical history of blood transfusion. The episode features an interview with Douglas Starr, PhD, author of Blood: An Epic History of Medicine and Commerce, and a conversation with Walter “Sunny” Dzik, MD, about the early history of blood transfusion.